Insider Trading activities of Innovate Biopharmaceuticals, Inc. (INNT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Innovate Biopharmaceuticals, Inc. (INNT) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Innovate Biopharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Innovate Biopharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is INNT. The reporting company's CIK number is 1551986.
The total value of stock buying since 2005 is $622,894.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Innovate Biopharmaceuticals, Inc. (INNT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-06 5,000 $5,815 0 $0 0 $0
2019-05 11,000 $14,779 0 $0 0 $0
2018-11 12,400 $32,987 0 $0 0 $0
2018-09 1,200 $7,279 0 $0 0 $0
2018-08 3,959 $19,763 0 $0 0 $0
2018-01 300,000 $105,000 0 $0 0 $0
2017-11 366,159 $164,771 0 $0 0 $0
2017-06 172,414 $100,000 0 $0 0 $0
2017-03 70,000 $105,000 0 $0 0 $0
2016-07 15,000 $67,500 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Innovate Biopharmaceuticals, Inc. insiders (INNT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-06-28 Laumas Sandeep (CEO, Executive Chairman) Buy 4,000 1.15 4,600
2019-06-13 Laumas Sandeep (CEO, Executive Chairman) Buy 1,000 1.22 1,215
2019-05-30 Madan Jay P. (President) Buy 5,000 1.32 6,600
2019-05-24 Proujansky Roy Buy 1,000 1.28 1,280
2019-05-22 Laumas Sandeep (CEO, Executive Chairman) Buy 5,000 1.38 6,899
2018-11-30 Proujansky Roy Buy 1,400 2.63 3,682
2018-11-30 Laumas Sandeep (Executive Chairman) Buy 3,000 2.63 7,890
2018-11-29 Prior Christopher P. (Chief Executive Officer) Buy 5,000 2.75 13,750
2018-11-29 Laumas Sandeep (Executive Chairman) Buy 3,000 2.56 7,665
2018-09-14 Prior Christopher P. (Chief Executive Officer) Buy 200 5.82 1,164
2018-09-12 Prior Christopher P. (Chief Executive Officer) Buy 500 6.13 3,065
2018-09-07 Laumas Sandeep (Executive Chairman) Buy 500 6.10 3,050
2018-08-30 Prior Christopher P. (Chief Executive Officer) Buy 309 5.20 1,606
2018-08-30 Laumas Sandeep (Executive Chairman) Buy 500 5.24 2,620
2018-08-28 Prior Christopher P. (Chief Executive Officer) Buy 1,000 4.93 4,930
2018-08-28 Laumas Sandeep (Executive Chairman) Buy 750 4.98 3,737
2018-08-27 Almenoff June Sherie (COO and Chief Medical Officer) Buy 400 4.93 1,973
2018-08-24 Almenoff June Sherie (COO and Chief Medical Officer) Buy 1,000 4.90 4,897
2018-01-26 Clarke David H (Former CEO and Director) Buy 300,000 .35 105,000
2017-11-29 Clarke David H (Former CEO and Director) Buy 366,159 .45 164,771
2017-06-23 Clarke David H (Former CEO and Director) Buy 172,414 .58 100,000
2017-03-16 Clarke David H (Former CEO and Director) Buy 70,000 1.50 105,000
2016-07-13 Clarke David H (Former CEO and Director) Buy 15,000 4.50 67,500

Insider trading activities including stock purchases, stock sales, and option exercises of INNT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Innovate Biopharmaceuticals, Inc. (symbol INNT, CIK number 1551986) see the Securities and Exchange Commission (SEC) website.